TARS
Tarsus Pharmaceuticals Inc
76.80$
+1.5%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.7% | 99.5% | 99.2% | 98.3% | 98.9% | 96.5% | 94.6% | 93.0% | |
| 98.6% | 99.4% | 97.8% | 95.8% | 31.4% | 84.7% | 25.2% | 32.7% | |
| 98.6% | 99.4% | 97.8% | 96.0% | 95.2% | 85.7% | 77.3% | 74.2% | |
| 0.2% | 0.1% | 0.0% | 0.1% | 1.6% | 6.7% | 12.7% | 15.5% | |
| – | 0.0% | – | 98.2% | 2.1% | 1.2% | 0.7% | 0.8% | |
| 0.3% | 0.5% | 0.7% | 0.4% | 0.4% | – | – | – | |
| – | – | – | – | – | 1.5% | 2.2% | 1.3% | |
| 156.7% | 110.3% | 3.5% | 6.8% | 15.3% | 25.8% | 40.4% | 38.9% | |
| 7.5% | 1.4% | 3.1% | 6.4% | 6.8% | 13.9% | 21.4% | 24.1% | |
| – | 0.1% | 0.2% | 0.7% | 0.3% | 0.1% | 0.2% | – | |
| 7.3% | 0.8% | 1.3% | 1.6% | 2.4% | 6.7% | 7.4% | 2.9% | |
| – | – | – | – | 8.5% | 11.2% | 19.1% | 12.9% | |
| -56.7% | -10.3% | 96.5% | 93.2% | 84.7% | 74.2% | 59.6% | 61.1% | |
| -57.1% | -10.3% | -19.1% | -26.1% | -47.7% | -92.2% | -95.5% | -75.9% | |
| 179.4% | 33.5% | 11.8% | 11.5% | 10.8% | 11.1% | 10.0% | 7.4% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.